Bristol-Myers Squibb Co (BMY)

NYSE · Pharmaceuticals

62.48
+1.09 (+1.78%)
Updated Oct 31, 6:24 PM ET
AI Rating
Hold
Overall Score
61
Trend
53
Momentum
63
Risk
70

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 16, 2025 260 sessions Oct 28, 2026

AI Analysis

Bristol-Myers Squibb Co is trading at $62.48, up 1.78% on the session. The 50 day average sits at $62.98 and the 200 day at $59.89, which puts the stock in a uptrend. RSI is at 47.6, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $58.33 with resistance near $62.25, so that band frames the current range. Average daily movement is roughly $1.67, or about 2.7% of the share price, which is what any stop placement has to allow for. The overall health score of 61 out of 100 combines a trend score of 53, momentum of 63 and a risk score of 70.

Technical indicators

RSI (14)
47.6
neutral
MACD
-0.255
bullish crossover
SMA 20
60.16
SMA 50
62.98
SMA 200
59.89
uptrend
ATR (14)
1.67
avg daily range
Support
58.33
Resistance
62.25
Volume vs 20d
0.58x
below average
Volatility
36.3%
annualised
1 month
-3.64%
3 months
-6.61%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.